Clinical Trials Browser

Phase 4 × rozanolixizumab × 30 days × Clear all

NCT07246564 2026-03-13

Phase 4 Study Evaluating Efficacy and Safety of Rozanolixizumab in Adult Chinese Participants With Generalized Myasthenia Gravis

Phase 4 Recruiting

Myasthenia Gravis